VIVOS INC. Secures $1.5M Private Placement
Ticker: RDGL · Form: 8-K · Filed: Sep 18, 2025 · CIK: 1449349
| Field | Detail |
|---|---|
| Company | Vivos Inc (RDGL) |
| Form Type | 8-K |
| Filed Date | Sep 18, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: private-placement, financing, medical-devices
TL;DR
VIVOS INC. raising $1.5M via private placement, closes late Sept.
AI Summary
VIVOS INC. announced on September 17, 2025, that it has entered into a definitive agreement for a private placement of its common stock. The company expects to raise approximately $1.5 million in gross proceeds from this offering, which is anticipated to close on or about September 25, 2025. These funds will be used for general corporate purposes.
Why It Matters
This private placement provides VIVOS INC. with crucial capital for its operations, potentially enabling further development or expansion of its business in the surgical and medical instruments sector.
Risk Assessment
Risk Level: medium — Private placements can dilute existing shareholders and the success of the company depends on the effective use of the raised capital.
Key Numbers
- $1.5M — Private Placement Proceeds (Gross proceeds expected from the offering)
- September 25, 2025 — Closing Date (Anticipated date for the completion of the private placement)
Key Players & Entities
- VIVOS INC. (company) — Registrant
- September 17, 2025 (date) — Date of earliest event reported
- $1.5 million (dollar_amount) — Gross proceeds from private placement
- September 25, 2025 (date) — Anticipated closing date of private placement
- Delaware (jurisdiction) — State of incorporation
- 3841 (sic_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
FAQ
What is the purpose of the $1.5 million raised?
The funds raised from the private placement are intended for general corporate purposes.
When is the private placement expected to close?
The private placement is anticipated to close on or about September 25, 2025.
What type of security is being offered in the private placement?
The filing indicates a private placement of common stock.
What is VIVOS INC.'s primary industry?
VIVOS INC. is classified under Standard Industrial Classification code 3841, which is for Surgical & Medical Instruments & Apparatus.
What was VIVOS INC.'s former name?
VIVOS INC. was formerly known as ADVANCED MEDICAL ISOTOPE Corp, with a name change date of November 3, 2008.
Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 12.2 · Accepted 2025-09-18 16:01:35
Filing Documents
- form8-k.htm (8-K) — 33KB
- 0001493152-25-014047.txt ( ) — 187KB
- rdgl-20250917.xsd (EX-101.SCH) — 3KB
- rdgl-20250917_lab.xml (EX-101.LAB) — 33KB
- rdgl-20250917_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. VIVOS INC. Date: September 18, 2025 By: /s/ Michael K. Korenko Name: Michael K. Korenko Title: Chief Executive Officer